(VIR) |
| 0 (0%) 10-10 07:12 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 7.45 |
| Resistance 1: | 6.38 |
| Pivot price: | 5.55 |
| Support 1: | 5.37 |
| Support 2: | 4.75 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -554710016.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -47.638 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -9.00 |
| Return on Assets (ttm) | 768.5 |
| Return on Equity (ttm) | -24.7 |
Company news
Thu, 09 Oct 2025
Rude Food by Vir Sanghvi: How the kulchette got its name, and other stories | Hindustan Times - Hindustan Times
Thu, 09 Oct 2025
Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTE - PharmiWeb.com
Thu, 09 Oct 2025
Vir Biotechnology announces first patient dosed in part 3 of phase 1 trial - MarketScreener
Thu, 09 Oct 2025
Vir Biotechnology (VIR) Advances Prostate Cancer Treatment with VIR-5500 Trial - GuruFocus
Thu, 09 Oct 2025
Vir Biotechnology doses first patient in prostate cancer combo trial By Investing.com - Investing.com South Africa
Thu, 09 Oct 2025
Vir Biotechnology (VIR) Surges 6.9%: Is This an Indication of Further Gains? - Nasdaq
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
